| 产品描述: | TC-MCH 7c 是一种苯基吡啶酮衍生物,一种口服有效的,选择性的且可穿透血脑屏障的 MCH1R 拮抗剂,对 hMCH1R 的 IC50 为 5.6 nM。TC-MCH 7c 对人和小鼠 MCH1R 的 Ki 分别为 3.4 nM 和 3.0 nM。 |
| 靶点: |
IC50: 5.6 nM (hMCH1R);Ki: 3.4 nM (hMCH1R) and 3.0 nM (mouse MCH1R) |
| 体外研究: |
TC-MCH 7c has an IC50 of 9.7 μM for MCH1R in [Ca2+]i mobilization. TC-MCH 7c has IC50s of 23 nM and 9.0 μM for FLIPR and hERG, respectively. |
| 体内研究: |
TC-MCH 7c (oral; 3-30 mg/kg; once-daily for 1.5 months) exhibits excellent body weight reduction in a dose-dependent manner in DIO mice model. TC-MCH 7c (oral; 3-30 mg/kg) with 30 mg/kg has plasma concentrations of 5.1, 1.8, and 0.7 μM at 2, 15, and 24 hours, respectively. |
| 参考文献: |
1. Ito M, et al. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice. Eur J Pharmacol. 2009 Dec 10;624(1-3):77-83.
2. Haga Y, et al. Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists. Bioorg Med Chem. 2011 Jan 15;19(2):883-93. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.448 ml |
12.241 ml |
24.482 ml |
| 5 mM |
0.49 ml |
2.448 ml |
4.896 ml |
| 10 mM |
0.245 ml |
1.224 ml |
2.448 ml |
| 50 mM |
0.049 ml |
0.245 ml |
0.49 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |